D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNDT
2126
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $2.93M | ﹤0.01% |
149,500
+129,500
| +648% | +$2.71M |
|
2127
Paychex
PAYX
$42.3B
| $2.92M | ﹤0.01% |
29,834
-315,625
| -91% | -$29.1M |
|
2128
Peapack-Gladstone Financial
PGC
$846M
| $2.92M | ﹤0.01% |
94,665
-14,815
| -14% | -$407K |
|
|
GES
2129
CALL
DELISTED
Guess Inc
GES
| $2.92M | ﹤0.01% |
+124,300
| New | +$3.06M |
|
2130
CALL
XPeng
XPEV
$12.2B
| $2.92M | ﹤0.01% |
+80,000
| New | +$3.33M |
|
2131
Mid-America Apartment Communities
MAA
$15.8B
| $2.92M | ﹤0.01% |
20,200
+8,187
| +68% | +$1.11M |
|
|
ATIP
2132
DELISTED
ATI Physical Therapy, Inc.
ATIP
| $2.91M | ﹤0.01% |
5,846
-5,239
| -47% | -$2.87M |
|
2133
Mistras Group
MG
$490M
| $2.91M | ﹤0.01% |
255,320
-17,814
| -7% | -$158K |
|
2134
CALL
Magnite
MGNI
$2.82B
| $2.91M | ﹤0.01% |
+70,000
| New | +$3.03M |
|
2135
EverQuote
EVER
$960M
| $2.91M | ﹤0.01% |
80,161
-47,472
| -37% | -$2.02M |
|
2136
CALL
SLB Ltd
SLB
$74.2B
| $2.91M | ﹤0.01% |
107,000
-146,100
| -58% | -$3.85M |
|
|
RMGCU
2137
DELISTED
RMG Acquisition Corp. III Unit
RMGCU
| $2.91M | ﹤0.01% |
+292,146
| New | +$3.04M |
|
|
HIMX
2138
Himax Technologies
HIMX
$2.09B
| $2.91M | ﹤0.01% |
212,889
-153,413
| -42% | -$1.79M |
|
|
LCAAU
2139
DELISTED
L Catterton Asia Acquisition Corp Units
LCAAU
| $2.9M | ﹤0.01% |
+291,885
| New | +$2.92M |
|
|
WOW
2140
DELISTED
WideOpenWest
WOW
| $2.9M | ﹤0.01% |
213,551
-2,566
| -1% | -$33.7K |
|
2141
Diageo
DEO
$49.4B
| $2.9M | ﹤0.01% |
17,656
-13,969
| -44% | -$2.29M |
|
2142
Zebra Technologies
ZBRA
$13.5B
| $2.88M | ﹤0.01% |
5,947
-8,290
| -58% | -$3.7M |
|
2143
Steris
STE
$22.4B
| $2.88M | ﹤0.01% |
15,112
-72,739
| -83% | -$13.5M |
|
2144
PUT
Eastman Chemical
EMN
$7.79B
| $2.87M | ﹤0.01% |
26,100
| – | – |
|
2145
Brink's
BCO
$4.87B
| $2.87M | ﹤0.01% |
36,263
-51,375
| -59% | -$3.88M |
|
2146
CALL
Fair Isaac
FICO
$31B
| $2.87M | ﹤0.01% |
5,900
| – | – |
|
2147
Arlo Technologies
ARLO
$1.55B
| $2.86M | ﹤0.01% |
455,329
-302,801
| -40% | -$2.37M |
|
2148
Lam Research
LRCX
$337B
| $2.86M | ﹤0.01% |
48,010
-431,510
| -90% | -$23.5M |
|
2149
CALL
Elastic
ESTC
$6.46B
| $2.85M | ﹤0.01% |
25,600
+10,100
| +65% | +$1.43M |
|
2150
CALL
WD-40
WDFC
$3.08B
| $2.85M | ﹤0.01% |
9,300
| – | – |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.